Esperion Therapeutics
ESPR
#6734
Rank
A$0.74 B
Marketcap
$3.79
Share price
2.49%
Change (1 day)
109.07%
Change (1 year)

Esperion Therapeutics (ESPR) - Total debt

Total debt on the balance sheet as of June 2024 : A$0.41 Billion

According to Esperion Therapeutics's latest financial reports the company's total debt is A$0.41 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Esperion Therapeutics - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$0.39 B1.88%
2022-12-31A$0.38 B6.84%
2021-12-31A$0.35 B48.84%
2020-12-31A$0.24 B10701.1%
2019-12-31A$2.23 M
2018-12-31N/A-100%
2017-12-31A$1.33 M-64.67%
2016-12-31A$3.78 M-35.69%
2015-12-31A$5.89 M-0.97%
2014-12-31A$5.94 M
2012-12-31A$21.91 M225.73%
2011-12-31A$6.72 M
2002-12-31A$15.6 M25.52%
2001-12-31A$12.43 M86.66%
2000-12-31A$6.66 M57.49%
1999-12-31A$4.22 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$57.52 M-86.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.92 B 123.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$102.30 B 24,652.26%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.15 B 904.70%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.68 B 65.22%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.15 B-62.55%๐Ÿ‡บ๐Ÿ‡ธ USA